Valeant Strikes Psoriasis-Drug Pact With AstraZeneca – Wall Street Journal
Wall Street JournalValeant Strikes Psoriasis-Drug Pact With AstraZenecaWall Street JournalPsoriasis is an autoimmune disease that causes a red, scaly rash and flaky skin. It affects around 7.5 million Americans, with around a quarter of these suffering from the moderate-to-severe form of the disease, according to the National Psoriasis …AstraZeneca reboots psoriasis drug in development deal with ValeantTelegraph.co.ukValeant to Work on Psoriasis With Astra After Amgen Bows OutBloombergChart of the day: Pharma majors chase psoriasis profitsInvestors Chronicle (blog)PPP Focus.comall 156 news articles »
[monetize id=”1″] [monetize id=”2″]
Best skin care cream for dry and irritated skin conditions
Psoriasis drug may aid diabetes treatment – Irish Health
Irish HealthPsoriasis drug may aid diabetes treatmentIrish HealthScientists have discovered that a drug that is currently used to treat the skin condition, psoriasis, could benefit people with type 1 diabetes. The news has been welcomed by the national diabetes charity, Diabetes Ireland. A team in the US discovered …and more »
https://www.dpsw.org/psoriasis-symptoms-a…
